LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

LLY

1,015.94

-0.68%↓

JNJ

194.16

-0.04%↓

ABBV

232.14

-1.25%↓

UNH

326.22

-2.02%↓

AZN

88.54

+0.6%↑

Search

Envista Holdings Corp

Atvērts

SektorsVeselības aprūpe

19.62 -2.34

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

19.4

Max

20.25

Galvenie mērījumi

By Trading Economics

Ienākumi

-57M

-30M

Pārdošana

-12M

670M

P/E

Sektora vidējais

222.778

105.69

EPS

0.32

Peļņas marža

-4.523

Darbinieki

12,300

EBITDA

9.6M

88M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+11.23% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-87M

3.3B

Iepriekšējā atvēršanas cena

21.96

Iepriekšējā slēgšanas cena

19.62

Ziņu noskaņojums

By Acuity

50%

50%

171 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

Envista Holdings Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 13. nov. 21:34 UTC

Peļņas

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

2025. g. 13. nov. 23:45 UTC

Tirgus saruna

Nikkei May Fall After Wall Street's Weakness -- Market Talk

2025. g. 13. nov. 23:42 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

2025. g. 13. nov. 23:41 UTC

Tirgus saruna

Gold Edges Higher on Possible Dip-Buying -- Market Talk

2025. g. 13. nov. 23:24 UTC

Peļņas

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

2025. g. 13. nov. 23:24 UTC

Peļņas

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

2025. g. 13. nov. 23:23 UTC

Peļņas

JBS NV 3Q EPS 52c >JBS

2025. g. 13. nov. 23:23 UTC

Peļņas

JBS NV 3Q Sales $22.6B >JBS

2025. g. 13. nov. 23:04 UTC

Tirgus saruna

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

2025. g. 13. nov. 22:02 UTC

Peļņas

Nu Holdings 3Q Net $783M >NU

2025. g. 13. nov. 22:01 UTC

Peļņas

Nu Holdings 3Q Rev $4.2B >NU

2025. g. 13. nov. 21:51 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

2025. g. 13. nov. 21:50 UTC

Peļņas

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

2025. g. 13. nov. 21:45 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

2025. g. 13. nov. 21:41 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

2025. g. 13. nov. 21:36 UTC

Iegādes, apvienošanās, pārņemšana

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

2025. g. 13. nov. 21:33 UTC

Tirgus saruna

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

2025. g. 13. nov. 21:33 UTC

Peļņas

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

2025. g. 13. nov. 21:31 UTC

Peļņas

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

2025. g. 13. nov. 21:25 UTC

Peļņas

Figure Tech Solutions 3Q Rev $156.4M >FIGR

2025. g. 13. nov. 21:25 UTC

Peļņas

Figure Tech Solutions 3Q EPS 34c >FIGR

2025. g. 13. nov. 21:23 UTC

Peļņas

Intchains Group 3Q Rev $1.3M >ICG

2025. g. 13. nov. 21:03 UTC

Peļņas

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

2025. g. 13. nov. 21:02 UTC

Peļņas

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

2025. g. 13. nov. 21:01 UTC

Peļņas

Applied Materials 4Q Rev $6.8B >AMAT

2025. g. 13. nov. 21:01 UTC

Peļņas

Applied Materials 4Q Gross Margin 48.0% >AMAT

Salīdzinājums

Cenas izmaiņa

Envista Holdings Corp Prognoze

Cenas mērķis

By TipRanks

11.23% augšup

Prognoze 12 mēnešiem

Vidējais 22.38 USD  11.23%

Augstākais 27 USD

Zemākais 18 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Envista Holdings Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

4

Pirkt

6

Turēt

1

Pārdot

Tehniskais rādītājs

By Trading Central

15.98 / N/AAtbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

171 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
help-icon Live chat